Jun 7, 2024 02:02PM
May 16, 2024 04:30PM
May 2, 2024 07:00AM
Apr 30, 2024 04:44AM
Apr 25, 2024 04:30PM
Apr 18, 2024 04:30PM
Apr 3, 2024 04:30PM Geron to Participate at Upcoming Investor Conferences in April
Mar 15, 2024 07:13AM
Mar 15, 2024 03:51AM
Mar 14, 2024 03:54PM
Mar 14, 2024 03:54PM
Feb 28, 2024 07:05AM
Feb 22, 2024 04:30PM
Feb 14, 2024 04:30PM Geron to Announce Fourth Quarter and Full-Year 2023 Financial Results on February 28, 2024
Jan 18, 2024 04:30PM
Jan 12, 2024 08:30AM
Dec 21, 2023 04:30PM
Dec 11, 2023 04:15PM
Dec 6, 2023 08:00AM
Dec 4, 2023 08:08AM
Dec 4, 2023 05:00AM Geron Announces Publication in The Lancet of Results from the IMerge Phase 3 Clinical Trial Evaluating Imetelstat in Lower Risk MDS
Nov 28, 2023 08:09AM
Nov 28, 2023 08:00AM
Nov 16, 2023 04:30PM
Nov 7, 2023 04:30PM
Nov 2, 2023 09:00AM
Nov 2, 2023 08:00AM
Oct 26, 2023 04:30PM Geron to Announce Third Quarter 2023 Financial Results on November 2, 2023
Oct 19, 2023 04:30PM
Sep 29, 2023 08:01AM
Sep 29, 2023 08:00AM
Sep 12, 2023 09:08AM
Sep 12, 2023 04:47AM
Sep 11, 2023 04:32PM
Sep 11, 2023 04:30PM Geron Announces Appointment of Michelle Robertson as Executive Vice President, Chief Financial Officer and Treasurer, and the Retirement of Olivia Bloom, Geron's Long-Time Chief Financial Officer
Sep 7, 2023 08:00AM
Sep 5, 2023 04:30PM
Sep 1, 2023 09:43AM
Aug 22, 2023 08:00AM
Aug 22, 2023 08:00AM
Aug 21, 2023 08:01AM
Aug 21, 2023 08:00AM Geron Announces FDA Acceptance of New Drug Application for Imetelstat for the Treatment of Lower Risk MDS
May 22, 2020 09:29AM

14,982 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All